Back
Arcosa, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
81
ACA
Arcosa, Inc.
Last Price:
$110.99
Seasonality Move:
4.41%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$70.00
Seasonality Move:
-34.19%
Buy
81
Arcosa, Inc. (ACA)
is a Buy
Is Arcosa, Inc. a Buy, Sell or Hold?
-
The current Arcosa, Inc. [ACA] share price is $111.17. The Score for ACA is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
ACA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACA Stock Price Chart
What is Arcosa, Inc.'s stock price today?
-
The Arcosa, Inc. share price today is $111.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACA is experiencing slight buying pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $71.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.67 | Buy |
| Relative Strength Index (14 RSI): | 63.53 | Buy |
| Chaikin Money Flow: | 6260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.35 - 110.99) | Buy |
| Bollinger Bands (100): | (91.7 - 104.68) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 72.85 | Buy |
| Chaikin Money Flow: | 1903413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.41 - 65.27) | Buy |
| Bollinger Bands (100): | (17 - 45.24) | Buy |
ACA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.37 | Buy |
| 20-day SMA: | 108.73 | Buy |
| 50-day SMA: | 101.84 | Buy |
| 200-day SMA: | 91.31 | Buy |
| 8-day EMA: | 110.48 | Buy |
| 20-day EMA: | 108.27 | Buy |
| 50-day EMA: | 103.56 | Buy |
| 200-day EMA: | 95.44 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.43 | Buy |
| 20-day SMA: | 52.92 | Buy |
| 50-day SMA: | 40.28 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 64 | Buy |
| 20-day EMA: | 55.88 | Buy |
| 50-day EMA: | 44.22 | Buy |
| 200-day EMA: | 31.26 | Buy |
Arcosa, Inc. Earnings Growth & ACA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $0.61 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Arcosa, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||